RUSHING to use medicinal cannabis for chemotherapy-induced nausea and vomiting (CINV) simply because it has become available is not always going to be the best option, because patients may miss out on effective treatments, according to an article published in MJA InSight this week.
Cancer Council Australia CEO Professor Sanchia Aranda explained, "Cannabis is not without its own side effects, and that needs to be considered."
In addition, current international and national clinical practice guidelines suggest there is insufficient evidence to recommend medicinal cannabis for routine use in this indication.
See doctorportal.com.au for more.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Nov 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Nov 18
